Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
Autor: | Liu, Ganqiang, Boot, Brendon, Cormier-Dequaire, Florence, Corvol, Jean-Christophe, Barker, Roger A, Heutink, Peter, Marinus, Johan, Williams-Gray, Caroline H, Scherzer, Clemens R, Progression, International Genetics of Parkinson Disease, Scherzer, C., Hyman, B. T., Locascio, Joseph J, Ivinson, A. J., Trisini-Lipsanopoulos, A., Franco, D., Burke, K., Sudarsky, L. R., Hayes, M. T., Umeh, C. C., Growdon, J. H., Schwarzschild, M. A., Hung, A. Y., Jansen, Iris E, Flaherty, A. W., Wills, A-M, Mejia, N. I., Gomperts, S. N., Khurana, V., Selkoe, D. J., Yi, T., Page, K., Liao, Z., Barker, R., Winder-Rhodes, Sophie, Foltynie, T., Williams-Gray, C. H., Mason, S., Winder-Rhodes, S., Breen, D., Cummins, G., Evans, J., Eberly, Shirley, Corvol, J-C, Brice, A., Elbaz, A., Mallet, A., Vidailhet, M., Bonnet, A-M, Bonnet, C., Grabli, D., Hartmann, A., Klebe, S., Elbaz, Alexis, Lacomblez, L., Mangone, G., Bourdain, F., Brandel, J-P, Derkinderen, P., Durif, F., Mesnage, V., Pico, F., Rascol, O., Forlani, S., Brice, Alexis, Lesage, S., Tahiri, K., van Hilten, J. J., Marinus, J., Duong, K., Ravina, Bernard, Dong, X., Hutten, S. J., Amr, S. S., Shoulson, I., Tanner, C. M., Lang, A. E., Nalls, M. A., van Hilten, Jacobus J |
---|---|
Přispěvatelé: | Human genetics, Amsterdam Neuroscience - Neurodegeneration, Neuro-Psycho Pharmacologie des Systèmes Dopimanégiques sous-corticaux (NPsy-Sydo), CHU Clermont-Ferrand-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Centre de recherche en épidémiologie et santé des populations (CESP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Neurologie et thérapeutique expérimentale, Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR70-Université Pierre et Marie Curie - Paris 6 (UPMC), Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute (ICM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Hertie Institute for Clinical Brain Research [Tubingen], University of Tübingen, Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Pierre et Marie Curie - Paris 6 (UPMC)-IFR70-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Centre National de la Recherche Scientifique (CNRS), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS) |
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: |
Male
0301 basic medicine Oncology medicine.medical_specialty [SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology Disease medicine.disease_cause genetics [Glucosylceramidase] etiology [Cognitive Dysfunction] 03 medical and health sciences 0302 clinical medicine Parkinson Disease/complications genetics [Parkinson Disease] Internal medicine Genetic variation medicine Humans Cognitive Dysfunction/etiology ddc:610 Longitudinal Studies Cognitive decline Allele ComputingMilieux_MISCELLANEOUS Aged Aged 80 and over Genetics genetics [Gaucher Disease] Mutation [SDV.NEU.PC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behavior Proportional hazards model [SCCO.NEUR]Cognitive science/Neuroscience Hazard ratio genetics [Cognitive Dysfunction] [SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciences Middle Aged Confidence interval 3. Good health 030104 developmental biology Neurology Glucosylceramidase/genetics Disease Progression Glucosylceramidase Female Neurology (clinical) complications [Gaucher Disease] complications [Parkinson Disease] Gaucher Disease/complications Psychology 030217 neurology & neurosurgery |
Zdroj: | Annals of Neurology, 80(5), 674-685. John Wiley and Sons Inc. Annals of Neurology Annals of Neurology, Wiley, 2016, 80 (5), pp.674-685. ⟨10.1002/ana.24781⟩ Liu, G, Boot, B, Locascio, J J, Jansen, I E, Winder-Rhodes, S, Eberly, S, Elbaz, A, Brice, A, Ravina, B, van Hilten, J J, Cormier-Dequaire, F, Corvol, J C, Barker, R A, Heutink, P, Marinus, J, Williams-Gray, C H, Scherzer, C R, Scherzer, C, Hyman, B T, Ivinson, A J, Trisini-Lipsanopoulos, A, Franco, D, Burke, K, Sudarsky, L R, Hayes, M T, Umeh, C C, Growdon, J H, Schwarzschild, M A, Hung, A Y, Flaherty, A W, Wills, A M, Mejia, N I, Gomperts, S N, Khurana, V, Selkoe, D J, Yi, T, Page, K, Liao, Z, Barker, R, Foltynie, T, Williams-Gray, C H, Mason, S, Winder-Rhodes, S, Barker, R, Williams-Gray, C H, Breen, D, Cummins, G, Evans, J, Winder-Rhodes, S, Corvol, J C, Brice, A, Elbaz, A, Mallet, A, Vidailhet, M, Bonnet, A M, Bonnet, C, Grabli, D, Hartmann, A, Klebe, S, Lacomblez, L, Mangone, G, Bourdain, F, Brandel, J P, Derkinderen, P, Durif, F, Mesnage, V, Pico, F, Rascol, O, Forlani, S, Lesage, S, Tahiri, K, van Hilten, J J, Marinus, J, Liao, Z, Page, K, Franco, D, Duong, K, Yi, T, Trisini-Lipsanopoulos, A, Dong, X, Sudarsky, L R, Hutten, S J, Amr, S S, Shoulson, I, Tanner, C M, Lang, A E & Nalls, M A 2016, ' Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's ', Annals of Neurology, vol. 80, no. 5, pp. 674-685 . https://doi.org/10.1002/ana.24781 Annals of neurology 80(5), 674-685 (2016). doi:10.1002/ana.24781 Annals of Neurology, 2016, 80 (5), pp.674-685. ⟨10.1002/ana.24781⟩ Annals of Neurology, 80(5), 674-685 2016, ' Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's ', Annals of Neurology, vol. 80, no. 5, pp. 674-685 . https://doi.org/10.1002/ana.24781 |
ISSN: | 0364-5134 1531-8249 |
DOI: | 10.1002/ana.24781⟩ |
Popis: | OBJECTIVE: We hypothesized that specific mutations in the β-glucocerebrosidase gene (GBA) causing neuropathic Gaucher's disease (GD) in homozygotes lead to aggressive cognitive decline in heterozygous Parkinson's disease (PD) patients, whereas non-neuropathic GD mutations confer intermediate progression rates.METHODS: A total of 2,304 patients with PD and 20,868 longitudinal visits for up to 12.8 years (median, 4.1) from seven cohorts were analyzed. Differential effects of four types of genetic variation in GBA on longitudinal cognitive decline were evaluated using mixed random and fixed effects and Cox proportional hazards models.RESULTS: Overall, 10.3% of patients with PD and GBA sequencing carried a mutation. Carriers of neuropathic GD mutations (1.4% of patients) had hazard ratios (HRs) for global cognitive impairment of 3.17 (95% confidence interval [CI], 1.60-6.25) and a hastened decline in Mini-Mental State Exam scores compared to noncarriers (p = 0.0009). Carriers of complex GBA alleles (0.7%) had an HR of 3.22 (95% CI, 1.18-8.73; p = 0.022). By contrast, the common, non-neuropathic N370S mutation (1.5% of patients; HR, 1.96; 95% CI, 0.92-4.18) or nonpathogenic risk variants (6.6% of patients; HR, 1.36; 95% CI, 0.89-2.05) did not reach significance.INTERPRETATION: Mutations in the GBA gene pathogenic for neuropathic GD and complex alleles shift longitudinal cognitive decline in PD into "high gear." These findings suggest a relationship between specific types of GBA mutations and aggressive cognitive decline and have direct implications for improving the design of clinical trials. Ann Neurol 2016;80:674-685. |
Databáze: | OpenAIRE |
Externí odkaz: |